Your browser doesn't support javascript.
loading
The role of gender in a large international OCD sample: A Report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) Network.
Benatti, Beatrice; Girone, Nicolaja; Celebre, Laura; Vismara, Matteo; Hollander, Eric; Fineberg, Naomi A; Stein, Dan J; Nicolini, Humberto; Lanzagorta, Nuria; Marazziti, Donatella; Pallanti, Stefano; van Ameringen, Michael; Lochner, Christine; Karamustafalioglu, Oguz; Hranov, Luchezar; Figee, Martin; Drummond, Lynne M; Grant, Jon E; Denys, Damiaan; Fontenelle, Leonardo F; Menchon, Jose M; Zohar, Joseph; Rodriguez, Carolyn I; Dell'Osso, Bernardo.
Afiliación
  • Benatti B; Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy; CRC 'Aldo Ravelli' for Neuro-technology and Experimental Brain Therapeutics, University of Milan, Milan, Italy. Electronic address: beatrice.benatti@unimi.it.
  • Girone N; Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy.
  • Celebre L; Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy.
  • Vismara M; Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy; CRC 'Aldo Ravelli' for Neuro-technology and Experimental Brain Therapeutics, University of Milan, Milan, Italy.
  • Hollander E; Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY, USA.
  • Fineberg NA; University of Hertfordshire, School of Life and Medical Sciences and Hertfordshire Partnership University NHS Foundation Trust, Rosanne House, Welwyn Garden City, United Kingdom.
  • Stein DJ; SA MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Nicolini H; Genomics of Psychiatric and Neurodegenerative Diseases Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico; Carracci Medical Group, Mexico City, Mexico.
  • Lanzagorta N; Carracci Medical Group, Mexico City, Mexico.
  • Marazziti D; Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Unicamillus-Saint Camillus International University of Health Sciences, Rome, Italy.
  • Pallanti S; Department of Psychiatry, University of Florence, Institute of Neurosciences, Florence, Italy.
  • van Ameringen M; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.
  • Lochner C; SA MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry, Stellenbosch University, South Africa.
  • Karamustafalioglu O; Department of Psychiatry, Sisli Eftal Teaching and Research Hospital, Istanbul, Turkey.
  • Hranov L; University Multiprofile Hospital for Active Treatment in Neurology and Psychiatry Sveti Naum, Sofia, Bulgaria.
  • Figee M; Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Drummond LM; National Services for OCD/BDD, St. George's, National Health Service Trust, London, United Kingdom.
  • Grant JE; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, IL, USA.
  • Denys D; Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Fontenelle LF; Turner Institute for Brain and Mental Health, Monash University, VIC, Australia; Obsessive, Compulsive, and Anxiety Spectrum Research Program, Institute of Psychiatry of the Federal University of Rio de Janeiro (UFRJ), D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil.
  • Menchon JM; Psychiatry Unit at the Hospital Universitari de Bellvitge-IDIBELL, University of Barcelona, Cibersam, Barcelona, Spain.
  • Zohar J; Post-Trauma Center, Research Foundation by the Sheba Medical Center, Tel Aviv University, Sackler School of Medicine, Israel.
  • Rodriguez CI; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
  • Dell'Osso B; Luigi Sacco University Hospital, Psychiatry 2 Unit, University of Milan, Milan, Italy; CRC 'Aldo Ravelli' for Neuro-technology and Experimental Brain Therapeutics, University of Milan, Milan, Italy; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Compr Psychiatry ; 116: 152315, 2022 07.
Article en En | MEDLINE | ID: mdl-35483201
INTRODUCTION: Obsessive-compulsive disorder (OCD) is characterized by a range of phenotypic expressions. Gender may be a relevant factor in mediating the disorder's heterogeneity. The aim of the present report was to explore a large multisite clinical sample of OCD patients, hypothesizing existing demographic, geographical and clinical differences between male and female patients with OCD. METHODS: Socio-demographic and clinical variables of 491 adult OCD outpatients recruited in the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) network were investigated with a retrospective analysis on a previously gathered set of data from eleven countries worldwide. Patients were assessed through structured clinical interviews, the Yale- Brown Obsessive-Compulsive Scale (Y-BOCS), the Montgomery-Asberg Depression Rating Scale (MADRS) and the Self-rating Depression Scale (SDS). RESULTS: Among females, adult onset (>18 years old) was significantly over-represented (67% vs. 33%, p < 0.005), and females showed a significantly older age at illness onset compared with males (20.85 ± 10.76 vs. 17.71 ± 8.96 years, p < 0.005). Females also had a significantly lower education level than males (13.09 ± 4.02 vs. 13.98 ± 3.85 years; p < 0.05), a significantly higher rate of being married (50.8% vs. 33.5%; p < 0.001) and a higher rate of living with a partner (47.5% vs. 37.6%; p < 0.001) than males. Nonetheless, no significant gender differences emerged in terms of the severity of OCD symptoms nor in the severity of comorbid depressive symptoms. No predictive effect of gender was found for Y-BOCS, MADRS and SDS severity. DISCUSSION/CONCLUSIONS: Our findings showed significant differences between genders in OCD. A sexually dimorphic pattern of genetic susceptibility may have a crucial role to OCD clinical heterogeneity, potentially requiring different specific therapeutic strategies. Further research is warranted to validate gender as an important determinant of the heterogeneity in OCD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno de Personalidad Compulsiva / Trastorno Obsesivo Compulsivo Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspecto: Determinantes_sociais_saude Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Compr Psychiatry Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno de Personalidad Compulsiva / Trastorno Obsesivo Compulsivo Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspecto: Determinantes_sociais_saude Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Compr Psychiatry Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos